FindTrial
Sign In

Safety and efficacy of very low dose co sulfamethoxazole dispersive tablets for the prevention of Pneumocystis jiroveci infection after renal transplantation

Safety and efficacy of very low dose co sulfamethoxazole dispersive tablets for the prevention of Pneumocystis jiroveci infection after renal transplantation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048850
Enrollment
Unknown
Registered
2021-07-18
Start date
2021-07-21
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney transplant

Interventions

case group:Nil

Sponsors

Renji Hospital affiliated to Shanghai Jiao Tong University Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. All renal transplant recipients who underwent renal transplantation surgery at the hospital from January 1, 2016 to June 30, 2021.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Scr;—

Countries

China

Contacts

Public ContactYuan Xiaodong

Renji Hospital affiliated to Shanghai Jiao Tong University Medical College

15736875970@163.com+86 15618069970

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026